| Product Name | N4-Hydroxycytidine |
|---|---|
| Description | N4-Hydroxycytidine is a broad spectrum antiviral with activity against a range of viruses including hepatitis C, norovirus, Ebola virus, influenza, respiratory syncytial viruses and coronaviruses. N4-hydroxycytidine has been shown to inhibit SARS-CoV-2 as well as other human and bat coronaviruses in mice and human airway epithelial cells. N4-hydroxycytidine is the active molecule in the antiviral pro-drug clinical candidate EIDD 2801, which is also being investigated for its broad spectrum activity against the coronavirus family of viruses. EIDD 2801 exerts its antiviral action through introduction of copying errors during viral RNA replication and is active against SARS, MERS and SARS-CoV-2. |
| Synonyms | 3258-02-4, CV-030, CV030 , Ebola virus, N4-Hydroxycytidine, SARS-CoV-2, antiviral, coronaviruses, hepatitis C, influenza, norovirus, respiratory syncytial viruses |
| Molecular Weight | 259.2 Da |
| Target | Antivirals |
| Amino Acid Sequence | 1-[2R,3R,4S,5R-3,4-Dihydroxy-5-hydroxymethyloxolan-2-yl]-4-hydroxyaminopyrimidin- 2-one |
| Form | White powder |
| Purity | >98% by hplc; NMR conforms |
| Cas Number | 04/02/3258 |
| Storage | Store desiccated, frozen and in the dark |
| References |
Janion and Glickman (1980) N4-hydroxycytidine: a mutagen specific for AT to GC transitions. Mutat. Res. 72(1) 43 PMID: 6160396Pyrc et al (2006) Inhibition of Human Coronavirus NL63 Infection at Early Stages of the Replication Cycle. Antimicrob. Agents Chemother. 50(6) 2000 PMID: 16723558Toots et al (2019) Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Sci. Trans. Med. 11(515) eaax5866 PMID: 31645453 Related areasAll small molecules >All antiviral agents > |
| Supplier | Isca Biochemicals Limited |
All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.
